News

IR Sant Pau Investigates Rare Diseases to Transform Diagnosis and Treatment

Rare diseases pose one of the greatest challenges for current biomedical research. Their low individual prevalence, clinical heterogeneity, and underlying molecular complexity hinder early diagnosis a...

IR Sant Pau Advances the Development of Fanconinib, a Pioneering Inhibitor Targeting a Key Cancer Pathway

The Sant Pau Research Institute (IR Sant Pau) has received funding from the national “Proof of Concept Projects 2025” call, promoted by the Ministry of Science, Innovation, and Universities throug...

Preeclampsia Leaves a Lasting Mark on the Cardiovascular System Years After Pregnancy, Even in the Absence of Apparent Symptoms

Preeclampsia is a pregnancy complication widely known for its immediate impact on maternal and fetal health. However, scientific evidence accumulated recently has shown that preeclampsia is also assoc...

An International Study Provides Long-Term Evidence on Bimekizumab in Plaque Psoriasis

An international clinical trial with three-year follow-up, the results of which have been published in JAMA Dermatology, provides new evidence on the long-term outcomes of patients with moderate to se...

The Memory Unit Celebrates 20 Years Consolidating Its Global Leadership in the New Era Against Alzheimer’s

Experts agree that today we are much closer to defeating Alzheimer’s and that we are living through a historic paradigm shift. There is still no cure, but for the first time it has been possible to ...